Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series

BACKGROUND: Hemoptysis is a clinical condition encountered in the emergency department (ED) and must be managed and investigated urgently to maintain the patient’s hemostasis. The management of hemoptysis depends on treating the underlying cause. Tranexamic acid (TXA) is an anti-fibrinolytic drug us...

Descripción completa

Detalles Bibliográficos
Autores principales: Alabdrabalnabi, Fatimah, Alshahrani, Mohammed, Ismail, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439666/
https://www.ncbi.nlm.nih.gov/pubmed/32819268
http://dx.doi.org/10.1186/s12245-020-00304-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439666/
https://www.ncbi.nlm.nih.gov/pubmed/32819268
http://dx.doi.org/10.1186/s12245-020-00304-x

Ejemplares similares